Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Relapsing Wernicke's encephalopathy after gastrectomy]

Koichi Arimura1, Hiroyuki Murai, Hitoshi Kikuchi

  • 1Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka.

Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
|September 30, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Effects and Feasibility of Virtual Reality Table Tennis in People With Parkinson's Disease in a Supervised Outpatient Setting: A Case Series.

Cureus·2026
Same author

Long-term effectiveness, safety, and cost-effectiveness of intravenous immunoglobulin for generalized myasthenia gravis in an era of molecular targeted drugs: Insights from Japanese post-marketing surveillance.

Journal of autoimmunity·2026
Same author

A pilot randomized study of multimodal rehabilitation using a virtual reality-based table tennis program in patients with Parkinson's disease.

Neurologia i neurochirurgia polska·2026
Same author

Long-Term Outcomes and Safety of Surgical Treatment Following Intracranial Electroencephalography Monitoring in Pediatric Epilepsy: A Single-Center Study.

Cureus·2026
Same author

[Imported Infectious Diseases of the Nervous System].

Brain and nerve = Shinkei kenkyu no shinpo·2026
Same author

Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026